Report overview
This report aims to provide a comprehensive presentation of the global market for Sleeping Pills (Prescription Drugs), with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Sleeping Pills (Prescription Drugs). This report contains market size and forecasts of Sleeping Pills (Prescription Drugs) in global, including the following market information:
Global Sleeping Pills (Prescription Drugs) Market Revenue, 2018-2023, 2024-2030, ($ millions)
Global Sleeping Pills (Prescription Drugs) Market Sales, 2018-2023, 2024-2030, (K Units)
Global top five Sleeping Pills (Prescription Drugs) companies in 2022 (%)
The global Sleeping Pills (Prescription Drugs) market was valued at US$ million in 2022 and is projected to reach US$ million by 2030, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is Forecast to Reach $ Million.
Zolpidem Segment to Reach $ Million by 2030, with a % CAGR in next six years.
The global key manufacturers of Sleeping Pills (Prescription Drugs) include Sanofi, Abbott Laboratories, Takeda Pharmaceutical, Apotex, Aurobindo Pharma, Actellon Pharmaceuticals, Allegiant Health, Cayman Chemical and Ambitropin, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
We surveyed the Sleeping Pills (Prescription Drugs) manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Sleeping Pills (Prescription Drugs) Market, by Type, 2018-2023, 2024-2030 ($ Millions) & (K Units)
Global Sleeping Pills (Prescription Drugs) Market Segment Percentages, by Type, 2022 (%)
Zolpidem
Eszopiclone (Lunesta)
Ramelteon (Rozerem)
Ativan (lorazepam)
Adapin (doxepin)
Global Sleeping Pills (Prescription Drugs) Market, by Application, 2018-2023, 2024-2030 ($ Millions) & (K Units)
Global Sleeping Pills (Prescription Drugs) Market Segment Percentages, by Application, 2022 (%)
Hospital Pharmacy
Retail Pharmacy
Global Sleeping Pills (Prescription Drugs) Market, By Region and Country, 2018-2023, 2024-2030 ($ Millions) & (K Units)
Global Sleeping Pills (Prescription Drugs) Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Sleeping Pills (Prescription Drugs) revenues in global market, 2018-2023 (Estimated), ($ millions)
Key companies Sleeping Pills (Prescription Drugs) revenues share in global market, 2022 (%)
Key companies Sleeping Pills (Prescription Drugs) sales in global market, 2018-2023 (Estimated), (K Units)
Key companies Sleeping Pills (Prescription Drugs) sales share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Sanofi
Abbott Laboratories
Takeda Pharmaceutical
Apotex
Aurobindo Pharma
Actellon Pharmaceuticals
Allegiant Health
Cayman Chemical
Ambitropin
Hayao
Outline of Major Chapters:
Chapter 1: Introduces the definition of Sleeping Pills (Prescription Drugs), market overview.
Chapter 2: Global Sleeping Pills (Prescription Drugs) market size in revenue and volume.
Chapter 3: Detailed analysis of Sleeping Pills (Prescription Drugs) manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Sleeping Pills (Prescription Drugs) in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Sleeping Pills (Prescription Drugs) capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.
